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Objective: Matrix-associated autologous chondrocyte implantation has been used to treat cartilage de-
fects. We developed a biphasic cylindrical osteochondral composite construct for such use, and con-
ducted this study to determine its feasibility for treating osteochondral lesions in human knees.
Method: Ten patients with symptomatic osteochondral lesions at femoral condyles were treated by
replacing pathological tissue with the construct of DL-poly-lactide-co-glycolide, whose lower body was
impregnated with b-tricalcium phosphate and served as osseous phase. The construct had a chamber to
load double-minced autologous cartilage, serving as source of chondrocytes. Osteochondral lesion was
drill-fashioned a pit of identical dimension as the construct. Chondrocyte-laden construct was press-ﬁt
to ﬁll the pit. Postoperative outcome was evaluated using Knee Injury and Osteoarthritis Outcome Score
(KOOS) scale up to 24 months. Magnetic resonance image was taken, and sample tissue was collected
with second-look arthroscopic needle biopsy at 12 months. Outcome parameters were primarily safety of
surgery, and secondarily postoperative change in KOOS and regeneration of hyaline cartilage and
cancellous bone.
Results: No patient experienced serious adverse events. Postoperative mean KOOS in “symptoms” sub-
scale had not changed signiﬁcantly from pre-operation until 24 months; whereas those in the other four
subscales were signiﬁcantly higher than pre-operation at 12 and 24 months. Second-look arthroscopy
showed completely ﬁlled grafted sites, with regenerate cartilaginous surfaces ﬂushed with surrounding
native joint surface. Microscopically, regenerated cartilage appeared hyaline.
Conclusion: This novel construct for chondrocyte implantation is safe for surgical application in knee. It
repairs osteochondral lesions of femoral condyles by successful regeneration of hyaline cartilage.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Focal articular cartilage and osteochondral defects are common
in working population. Lesions in weight-bearing joints such as
knee impair quality of life as much as severe osteoarthritis1.
Untreated full-thickness cartilage defects in adults heal poorly and
can progress to catastrophic arthritis2. Conventional surgeries,
including debridement, abrasion chondroplasty, and marrow
stimulation such as microfracture are successful only in young
patients with small lesions3. Osteochondral autografting such as
mosaicplasty has good clinical results, but its use is restricted to
small lesions because of morbidity at larger donor sites4. Recent: C.-C. Jiang, Department of
ital, 7 Chungsan South Road,
ax: 886-2-23939632.
v.tw (C.-C. Jiang).
s Research Society International. Padvances in autologous chondrocyte implantation (ACI) have yiel-
ded more promising outcomes through successful repair of defects
using regenerated cartilage5. The clinical results are comparable or
superior to conventional surgeries3.
ACI continues to evolve around two major issues: ways of
obtaining an adequate number of chondrocytes to regenerate car-
tilage, and secure implantation of cells to defect site4. In earlier
models of ACI, defect was sealed over with a membrane, and cell-
suspension was injected behind the membrane. This process
required delicate surgical techniques and bore concerns about
uneven cell distribution and cell leakage6. In order to overcome
these problems, biodegradable scaffolds serving as cell carriers
were developed for matrix-associated autologous chondrocyte
implantation (MACI). MACI was originally the product name of
a type I/III collagen ﬂeece (Verigen, Leverkusen, Germany); the cell-
seeded ﬂeece was glued onto a prepared chondral defect. The
procedure could be performed more easily than ACI and yielded
comparable clinical results7. Some scaffolds consisting of variousublished by Elsevier Ltd. All rights reserved.
Fig. 1. Biphasic cylindrical scaffold ready for cell seeding. About 1.5 mm below the top
(indicated by the arrow) of the cylinder is the soft spongy chondral phase, and the
remainder is the more rigid osseous phase. The osseous phase is a barrel-and-plug
construct. The inlay picture shows complete construct after assembly, with the plug
being outlined by solid lines. The ﬂat space (indicated by the arrow) between the plug
top and chondral phase serves as the chamber for enzyme-dissociated autologous
cartilage.
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implant attachment has been debated10,11; inadequate security of
implantation may lead to dehiscence of the implant from bone
during joint motion. Furthermore, many cartilage lesions such as
osteonecrosis and osteochondritis dissecans are associated with
pathology of subchondral bone. Any treatment of a surface chon-
dral lesionwithout support from an intact subchondral bed is likely
to fail12. One study combined autologous bone grafts and MACI to
treat osteochondral lesions13, but the surgical procedures were
complicated. A more convenient solution could be a pre-fashioned,
biphasic osteochondral composite which self-secures to defect site
without additional ﬁxation and mends both cartilage and sub-
chondral bone. The clinical success of mosaicplasty with osteo-
chondral grafts supports this approach14,15. Many biphasic
osteochondral constructs have been designed recently16e18, but
few have been used clinically.
Previous in vitro studies indicated a need for a large number of
chondrocytes to engineer cartilage19. Because autologous donor car-
tilage is extremely scarce, harvested chondrocytes need to be culture-
expanded before being implanted during a second surgery. Recent
studies indicated that chondrocytes of lower seeding density on
selected biomaterial scaffolds can synthesize good cartilage in vivo
without prior monolayer expansion20,21, probably because the carti-
lage defect environment acts as a “bioactive chamber” with natural
settings22. An alternative to avoid culture-expansion of cells is the
implantation of minced cartilage, which has been proved as an effec-
tive intraoperative cell source for cartilage repair23. These ﬁndings
havemade graft harvest and implantationpossible in a single surgery.
On the basis of these concepts, we developed a novel bio-
degradable biphasic osteochondral construct for implantation of
minced autologous cartilage as the source of chondrocytes to repair
cartilage defects24. The construct was loadedwith “double-minced”
autologous cartilage which was processed sequentially by me-
chanical mincing using a power-driven pulverizer and by chemical
mincing using enzymatic dissociation. The minced cartilage-loaded
construct was implanted to repair osteochondral lesion in a single-
stage, seed-and-implant surgery. The surgical applicability and
standardized surgical procedures for this construct had been veri-
ﬁed in a porcine model in which regeneration of hyaline cartilage
successfully repaired artiﬁcially created osteochondral defects in
the knee joints25. We conducted this human clinical feasibility
study to verify the safety of the surgical application of this construct
to repair osteochondral lesions on femoral condyles of knee joints.
The efﬁcacy of this construct in regenerating cartilage and
improving symptoms was also evaluated.
Methods
Biomaterial
The biphasic construct was fabricated with a modiﬁed solvent
merging/particulate leaching method as previously described24.
The product was a cylindrical plug, 8.5 mmwide and 8.5 mm high
(Fig. 1). About one-sixth of height of the cylinder was polylactic-co-
glycolic acid (PLGA) , and it served as the chondral phase. The
remainder was comprised of a PLGA-tricalcium phosphate (TCP)
composite, and it served as the osseous phase. A ﬂat chamber,
6.5 mm wide and 1 mm thick, lay between the two phases and
served as the reservoir space for processed autograft.
All products were fabricated in a good manufacturing practice
(GMP) compliant laboratory, and had passed preclinical evaluations
including toxicology tests and animal experiments24,26. Efﬁcacy of
the biphasic constructs to regenerate cartilage in knee joint, and
applicability of the surgical procedures and instruments, had been
testiﬁed on a porcine model8,21.Patient recruitment and baseline evaluation
The protocol for this prospective clinical feasibility study was
approved by Institutional Review Board of the corresponding au-
thor’s hospital, and the national ministry of health with full com-
pliance to national legal regulation on clinical trial, and the Helsinki
Declaration. Consecutive patients with symptomatic osteochondral
lesions visiting our clinic who fulﬁlled the following inclusion cri-
teria were invited to participate in the study: (1) age 18e60 years
and having a symptomatic osteochondral lesion of the femoral
condyle of knee joint, as diagnosed by plain roentgenography and
magnetic resonance imaging (MRI); (2) skeletally mature as
determined with plain roentgenography, with closure or absence of
physeal plate at distal femur and proximal tibia; (3) a lesion whose
largest dimension did not exceed 20 mm, as measured with MRI,
and (4) a lesion of grades 3 or 4, according to Dipaola’s classiﬁcation
with MRI27. We excluded patients with unhealed fractures in either
lower limb, diffuse degenerative changes in cartilage in the object
knee, serologically conﬁrmed rheumatism, metabolic arthropathy
such as gouty arthritis, and knee stiffness for any reason with
a ﬂexion contracture exceeding 20 and/or maximal ﬂexion less
than 130, and those who were pregnant. During implantation
surgery, the lesion was ﬁrst re-evaluated with arthroscopy. Only
lesions of grades 3 or 4 as per Guhl’s classiﬁcation28 were subjected
to implantation;milder lesions were debrided arthroscopically, and
patients with these lesions were excluded from the study.
A cohort of 12 patients was eligible, 10 of whom were included
in the study: six men and four women, with average age of 27.6
years. All 10 lesions (ﬁve on lateral condyle and ﬁve on medial
condyle) were osteochondral, as being depicted by MRI. The MRI
ﬁndings of these lesions were uniform, featuring well-deﬁned
osteochondral area with intermediate signal in all sequences that
clearly delineate the pathological tissue from the host bone (Fig. 2).
Three patients had undergone operations in the object knees: one
had reconstruction of anterior cruciate ligament with an ipsilateral
bone-patellar tendon-bone autograft 2 years earlier, one had
arthroscopic debridement for the osteochondral lesion 1 year prior,
and one had repair of the osteochondral lesion with an autologous
periosteal patch 1 year prior. The latter two lesions failed to
regenerate cartilage in the chondral defects.
Every participating patient signed an informed consent before
surgery, and an independent study nurse interviewed the patients
and assisted themwith self-assessment of knee functionwhich was
Fig. 2. Example implantation surgery. A 32-year-old man had an osteochondritis dissecans lesion at the distal surface of the medial femoral condyle in his left knee. (A) The lesion
was hardly depicted on the plain X-ray ﬁlm by a vague margin (indicated by the arrow). (B) Coronal acquisition of MRI with FSE sequence clearly demonstrated the lesion by its
lower signal than that of the host bone, with a sharp and smooth boundary to demarcate the lesion (indicated by the arrow). The boundary did not contain a high signal zone,
indicating a stable type of osteochondritis dissecans. (C) During surgery, the triangular lesion was about 10 mmwide, and contained soft necrotic osteochondral tissue. Autologous
cartilage tissue was harvested from along the margins on both sides of the medial condyle. The lesion was drilled to a cylindrical pit with dimensions identical to those of the
biphasic construct. (D) The prepared construct was press-ﬁt to the recipient site so that its surface was ﬂush with the articular surface.
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(KOOS) questionnaire. Patients used a 100 mm visual analog scale
(VAS) to indicate pain in the subject knee joints while they sat
down and arose from a chair or alternatively squatting.
Surgical procedures and postoperative protocol
All surgeries were performed by a medical teamwhich included
the authors. Under spinal anesthesia, the knee joint ﬁrst underwent
routine arthroscopy to conﬁrm site and condition of the lesion.
Depending on the lesion site, a lateral or medial minimal para-
patellar arthrotomy was made to expose the lesion. An 8-mm
diameter circle was marked with a punch, with its edge being
placed at junction of the lesion and neighboring native healthy
cartilagewhen the lesionwas larger than circular area of the punch,
or fully covering the lesion when the lesion was smaller. A max-
imum of three circles were made in a mosaic fashion to cover large
lesions. Cartilage within the circles, if it was of acceptable quality,
was excised and retained as part of the autograft. Additional
autograft was harvested from non-articulating margin of the
affected condyle by curettage. All graft was collected in a special
measure container, and a total packed volume of 0.15 cm3 cartilage
was harvested. Holes were drilled into the subchondral cancellous
bone using a specially designed drill and guide to form cylindrical
pits 8.5 mm in diameter and 8.5 mm deep from articular surface.
The collected cartilage graft was immersed immediately in
sterile saline and morcelized with a specially designed tissue pul-
verizer with a sieve to obtain particles smaller than 1,000 mm.
Collagenase (Librase, Roche Diagnostics, Mannheim, Germany) was
added to further dissociate the tissue particles at 37C for 20 min.
The dissociated tissuewas rinsed three times with 20ml of saline to
remove residual collagenase, resuspended in 0.8 ml saline, and
transferred with a syringe to the chamber of the biphasic implant.
At the time of graft implantation, the prepared biphasic con-
structs were manually press-ﬁt in the cylindrical defects such that
surface of the chondral phase appeared ﬂush with the articular
surface (Fig. 2). One lesion required two constructs, another onerequired three constructs, and the others needed a single construct
each to repair the majority of the lesion, if not the entire lesion. The
wound was closed in layers. A knee brace was applied that
restricted knee motion from 0 to 90 ﬂexion. Patients were
instructed to walk partial weight bearing on the operated leg using
crutches, immediately after recovery from anesthesia. Patients
were discharged on the third postoperative day, andwound healing
was conﬁrmed at out-patient clinic 1 week later. A brace was used
for 6 weeks postoperatively. Patients were not allowed to partic-
ipate in vigorous sports activities until 6 months postoperatively.
Follow-up evaluation
KOOS and VAS score were evaluated in follow-up clinics at 6
weeks and 3, 6, 12, and 24 months. Any adverse events (AEs) and
serious AEs (as deﬁned by the US Food and Drug Administration29)
that caused disability of operated limb or required another hospi-
talization were recorded.
Plain roentgenography, MRI, and second-look arthroscopy were
done at 12 months postoperatively. Acquisition of MRI from a 1.5 T
machine (GE Sigma EXCITE) included at least fast spin-echo (T2-
FSE) and 3-dimensional fat-suppressed gradient-echo (3D-GE-FS)
sequences. The repair site was identiﬁed during arthroscopy, and
a sample of regenerated tissue was collected from the center using
a 1-mm diameter biopsy trephine driven perpendicular to surface
of the repair to about 10 mm deep. The harvested sample of re-
generated osteochondral tissue was formalin-preserved, decal-
ciﬁed overnight in sodium citrate-formic acid solution, and
embedded in parafﬁn. The embedded specimen was then micro-
sectioned for routine hematoxylin-eosin (HE) staining, Alcian blue
staining for proteoglycan, and immunohistological staining for
collagen type II (Chemicon, Temecula, CA). The regenerated tissue
slide was evaluated using microscopy and by the ICRS (Interna-
tional Cartilage Repair Society) Visual Histological Assessment
Scale30. The regenerated osteochondral tissue was deﬁned as of
acceptable quality when none of the scores in the scale, including
surface, matrix, cell distribution, cell population viability,
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Regenerated cartilage was deﬁned as being hyaline when the
ground substance was homogeneous without ﬁbrous texture as
determined with HE staining, was positively stained with Alcian
blue, demonstrated a predominance of collagen type II with
immunohistological staining, and had round viable cells existing
individually or in short columns in lacunae. Cells were considered
viable if HE staining revealed a clearly delineated nucleus31.
Photo images of the lesion sites obtained during arthroscopy
from all patients before and 12 months after the repair surgery
were inspected in random order by an orthopedic surgeon blinded
to source of the images. Each lesion was scored using a previously
proposed gross grading scale31. MRI of the lesion sites at 12 months
postoperatively was interpreted by an independent radiologist, to
evaluate quality of the regenerate tissue by the revised MOCART
(Magnetic resonance Observation of Cartilage Repair Tissue)
scale32.
Statistic analysis
Surgical safety was determined by detecting postoperative
occurrence of any serious AE or AE, and by calculating the pro-
portion of each of such events at 95% conﬁdence interval (CI), using
the Borkowf’s method of constructing binomial CIs with near
nominal coverage33.
The KOOS questionnaire includes ﬁve subscales, namely pain
(Pain), other symptoms (Symptoms), activities of daily living (ADL),
sports and recreational activities (Sport/Rec), and quality of life
(QoL). For each patient, score of each subscale was analyzed sepa-
rately. Raw scores in a subscale were summed, normalized, and
transformed as instructed in the KOOS manual. The ﬁnal score of
a subscalewas a percentage score reversely proportional to severity
of the problem, with 100 indicating no problem at all. Mean KOOS
and mean VAS score of all 10 patients at each time of follow-up
were respectively compared with the pre-operative value using
Wilcoxon signed rank test, with P < 0.05 regarded as statistically
signiﬁcant difference for each comparison. Mean gross grading
scores of all 10 patients at 12-month follow-up were compared
with the pre-operative value in the same way. Statistic calculations
were done with SPSS software (version 16.0.1, SPSS Inc., Chicago, IL)
on a Microsoft Windows-based computer.
Results
All 10 patients completed the 2-year follow-up. There were no
complication such as infection or serious hemarthrosis during
postoperative period; all wounds healed well by 1 week after sur-
gery. Minor AEs, including moderate swelling of knee joints and
soreness of knee joint during motion, were recorded at 6-week
follow-up (Table I). All of these problems disappeared at 3-month
follow-up without treatment. No patient experienced any serious
AE during the entire follow-up period.
Postoperative mean KOOS in the Symptoms subscale had not
changed signiﬁcantly from mean pre-operative value until 24
months, when the KOOS became signiﬁcantly higher than pre-Table I
Proportion of AEs after implantation of chondrocyte-laden biphasic construct as in
this series of patients (n ¼ 10) and as calculated at 95% CI using Borkowf’s method33.
Proportion n ¼ 10 95% CI
Serious AE, any 0 0w 0.30
Minor AE
Knee swelling 0.4 0.02 w 0.81
Soreness at knee motion 0.3 0 w 0.71operation. For all the other four subscales, postoperative mean
KOOS at 12months and at 24monthswere signiﬁcantly higher than
pre-operation. Mean VAS scores at chair rise decreased gradually
postoperatively and were signiﬁcantly lower than the pre-
operative value after 3 months. Postoperative mean VAS scores at
squatting had been insigniﬁcantly lower than the pre-operation
until 24 months, when the difference became signiﬁcant (Fig. 3).
Plain roentgenography at 12 months showed radiopaque tra-
becule within the original bony pit at grafted site. However, MRI
signal from the content within bony pit differed from that from the
neighboring native bone, so that the bony graft sitewas demarcated
with a blurred boundary. In seven patients, second-look arthro-
scopy showed that the grafted sites were completely covered with
cartilaginous tissue with a ﬂush smooth surface that integrated
well with adjacent native cartilagewithout a gap. In the other three
patients, cartilage regeneration within the lesion was incomplete,
and cartilage was intermingled with coarse ﬁbrous tissue and pits
exposing the subchondral bone (Figs. 4 and 5). Mean gross score at
12 months was signiﬁcantly higher than the pre-operative value
(12.9 vs 5.5).
Gross appearance of the biopsy specimens typically demon-
strated a tri-layer cylinder with seamless bonding between layers.
The opaque white cartilage was approximately 2 w 3 mm thick,
followed by a thin, clearer zone that gradually transitioned into
cancellous bone tissue. In the brownish bony tissue, residual TCP
biomaterial was visible as a chalky substance encapsulated in
a clearer matrix. Histological examinations revealed regenerated
cartilaginous tissue in the chondral phase without residual bio-
material. The cartilage was hyaline in nature, with viable cells
evenly distributed in a mixed columnar-cluster pattern (Fig. 6).
Tissues in all specimens were graded as acceptable quality using
ICRS scale, andwere all positively stainedwith Alcian blue andwith
immunohistological staining for collagen type II.
MRI appearance of the repaired site at 12 months post-
operatively (Fig. 7) paralleled arthroscopic and histological ﬁnd-
ings. During systematic review of the regenerated cartilage with
MOCART scale (Table II), the variables “degree of defect repair/ﬁll-
ing of defect”, “integration to border zone”, and “surface of repair
tissue” were compatible with the arthroscopic ﬁnding, and the
variable “structure of repair tissue” was compatible with the his-
tological ﬁnding of biopsy specimen.
Discussion
This study was designed to evaluate the clinical feasibility of
repairing osteochondral defects with a novel biphasic biomaterial
with a single seed-and-implant surgery.
This biphasic construct has a spongy chondral phase covering
a ﬂat chamber, which serves as a reservoir for implanted cells. An
essential factor for successful ACI is secure retention of implanted
cells at the recipient site, where the chondrocytes deposit chondral
matrix and build cartilage. MACI uses a porous scaffold to retain
cells, largely by adhesion of cells to inner surface of the construct.
The design of a scaffold should be optimized to support cell growth,
to allow nutrient transport, and to prevent cell loss34. Some scaf-
folds use sophisticated techniques, such as conjugating RGD (Arg-
Gly-Asp) peptide to the biomaterials, to enhance chondrocyte
attachment35. The unique design of our construct is expected to
hold chondrocytes in the construct. Cells in the reservoir chamber
are actually double-minced cartilage fragments instead of free in-
dividual chondrocytes. The concept of cartilage regeneration using
minced cartilage resembles that of autogenous bone grafting,
a common clinical practice in which morcelized cancellous bone is
grafted at a fracture site to build callus for bone union. There is an
inverse relationship between cartilage fragment size and amount of
Fig. 3. Clinical outcome. Asterisks indicate a signiﬁcantly higher value, and the pond sign indicates a signiﬁcantly lower value, than the pre-operative value. (A) Mean KOOS for
subscales (see text for abbreviations). The mean KOOS for the “function, sports and recreational activities” subscale at 6 weeks was the only item that was signiﬁcantly lower than
the pre-operative value. (B) Mean VAS score.
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cartilage because the highest level of cellular activity is localized at
the fragment edge36. Therefore the cartilage should be intensively
minced to obtain the largest total surface area for optimal growth of
repair cartilage.We used a double-mincing system for this purpose.
Autologous cartilage was ﬁrst mechanically minced to tiny frag-
ments by the tissue pulverizer, and was further chemically minced
by enzymatic dissociation of the ground substance. These pro-
cedures created clusters of chondrocytes entrapped in a loose
matrix, and allowed the cells to be slowly released as the matrix
broke down, causing the cells to migrate into the spongy chondral
phase of the construct after implantation. Contents of matrix such
as type II collagen, chondroitin sulfate, and hyaluronan help pre-
serve phenotype of implanted chondrocytes37,38.
Our previous in vivo studies showed that chondrocytes released
from degrading cartilage fragmentsmove into PLGA chondral phase
instead of entering TCP-containing osseous phase25,26. The basis for
this may be from a more active exchange of ﬂuid in the chondral
phase with joint motion. When the spongy chondral phase is
compressed, the ﬂuid content is squeezed into the joint space. As
the compression is released, negative pressure in the chondral
phase draws free cells in the reservoir chamber into the spongy
space. Another possible reason why chondrocytes stayed away
from osseous phase is the hypothetic “material preference” of
chondrocytes. A report on an in vitro study with a similar biphasic
construct with PLGA/TCP in osseous phase indicated that seeded
chondrocytes preferentially stayed in the chondral phase of PLGA16.The in vivo formation of subchondral cancellous bone is con-
sidered independent of pre-seeding osteogenic cells to the con-
struct21,39. The porous construct absorbs host marrow, which
contains osteogenic stromal cells, and undergoes osteogenesis
when exposed to TCP content in the construct40e42. TCP has good
osteoconductivity when used as a biomaterial implant and may
enhance afﬁnity of the implant to the host bone43,44. We observed
bone formation in osseous phase of all specimens, with remodeling
along the implantehost interface. However, cell-based bio-
resorption of TCP is a slow process, with possible long-term per-
sistence of this ceramic material39. Although PLGA in chondral
phase of our constructs dissolved completely, residual TCP content
in osseous phase was observed 12 months after implantation.
All 10 lesions on our patients were osteochondral that involved
pathology of both cartilage and bone. However, plain X-ray image
clearly depicted the lesion in only four patients. MRI is the most
widely accepted tool to identify osteochondral lesions in the knee,
with high sensibilityand speciﬁcity45,46. All lesions inour serieswere
clearly demonstrated by MRI by different intralesional signal from
host bone in all sequences. The Articular Cartilage Imaging Com-
mittee of ICRS has recommended a detailed procedure of imaging for
surgically regenerated cartilage32. With selective sequences, MRI
acquired from standard 1 or 1.5 T scanners can well depict mor-
phology and structure of the regenerated cartilage47. This held true
with our ﬁndings: the MRI appearance of regenerated cartilage par-
alleled visual ﬁndings through arthroscope, and could be a non-
invasive alternative to illustrate the outcome of cartilage repair.
Fig. 5. Outcome of osteochondral regeneration: gross appearance of the lesion (upper panel) as observed through mini-arthrotomy, and arthroscopic ﬁnding of the lesion (lower
panel) at 12 months after the implantation surgery. (A) A full-layer cartilage defect on the distal portion of lateral femoral condyle in the right knee of a 21-year-old female. (B) An
osteochondral lesion on the distal portion of lateral femoral condyle in the right knee of a 25-year male, with the cartilage detached as a ﬂap from the underlying necrotic bone. (C)
A full-layer cartilage defect on the lateral femoral condyle in the left knee of a 32-year-old male. The repair cartilage was thin, with residual chalky biomaterial in the osseous phase
of implanted construct visible through the neocartilage. (D) An osteochondral lesion on the lateral femoral condyle in the left knee of a 34-year-old female. (E) A full-layer cartilage
defect on the lateral femoral condyle in the left knee of a 49-year-old male.
Fig. 4. Outcome of osteochondral regeneration. (Upper row) Arthroscopic ﬁnding of the grafted osteochondral lesion shown in Fig. 2 at 12 months after the implantation surgery.
(A) The recipient site was ﬁlled with cartilage-like tissue that seamlessly merged with the surrounding native cartilage. Arrow-heads indicate the junction of the regenerated and
native tissue. The surface of the regenerated cartilage was smooth and mildly humped from the articular surface. (B) Needle biopsy was used to collect a sample of the regenerated
tissue. The inlayed picture shows the gross appearance of the sample. (Lower row) Another 24-year-old man had osteochondral lesion on the lateral femoral condyle of his left knee.
(C) Plain roentgenography showed the lesion with a detached bone chip. (D) At 12-month postoperation, the surgically created pit at the grafted site was ﬁlled with radiopaque
trabecule. Black arrows indicate contour of the bony pit. (E) MRI (coronal acquisition with T1 sequence) at 12-month still clearly demarcates the bony pit, which is depicted by
a signal different from the native cancellous bone. White arrows indicate interface between graft and host bone.
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Fig. 6. Biopsy specimen from the regenerated tissue of a 19-year-old male patient. (A) Gross appearance. (B1, B2) Microscopic appearance of the regenerated bone in the osseous
phase indicated by 1 and 2, respectively, in the specimen shown above, after decalciﬁcation and HE staining. The chalky residual of biomaterial TCP in region 2 was removed during
the decalcifying process. (C) Histological appearance of the regenerated cartilage in the chondral phase, with HE staining. The matrix was a homogeneous ground substance without
coarse ﬁbrous texture; the cells were alive and distributed in a columnar (indicated by the black arrows) or cluster (indicated by the white arrow) pattern.
Table II
MRI evaluation of the repaired sites at 12 months postoperatively by MOCART scale.
Variables Number
of patients
(Total n ¼ 10)
1. Degree of defect repair/ﬁlling of defect
Complete 4
Hypertrophy 5
Incomplete, >50% thickness of adjacent cartilage 1
Incomplete, <50% thickness of adjacent cartilage 0
H. Chiang et al. / Osteoarthritis and Cartilage 21 (2013) 589e598 595Very few scales for a systemic review on MRI of regenerated
cartilage are found in the literature. We relied primarily on
arthroscopic and histological ﬁndings to assess the repair tissues,
but also used the revisedMOCART scale to evaluateMRI appearance
of such tissues. A difﬁculty to use MOCART scale for our osteo-
chondral repair was its original design for cartilage-only repair. The
“subchondral lamina” and “subchondral bone” variables in the
scale pertain to native bone under the implanted chondral graft.
However, both subchondral lamina and subchondral bone were
pathological in our patients, and were replaced by the biphasic
construct. Although histology of the regenerated tissue showedFig. 7. MRI image (sagittal acquisition of T2-FSE sequence) of the repaired site at 12
months postoperation. The implanted site is identiﬁed by the hypo-intense square pit
in the subchondral bone, and is completely ﬁlled with neocartilage of similar thickness
with the neighboring native cartilage. The neocartilage integrates well to border zone
(indicated by the arrows) without a cleft, has intact surface and subchondral lamina,
and is homogeneous in texture.
Subchondral bone exposed 0
2. Integration to border zone
Complete 9
Incomplete with split-like border 1
Incomplete with visible defect <50%
length of repair tissue
0
Incomplete with visible defect >50%
length of repair tissue
0
3. Surface of repair tissue
Intact 9
Damaged by <50% depth of repair tissue 1
Damaged by >50% depth of repair
tissue/total degeneration
0
4. Structure of repair tissue
Homogeneous 7
Inhomogeneous or cleft formation 3
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generated bone was consistently more hypo-intense than host
bone onMRI. In nine patients, subchondral lamina rebuilt onMRI at
12 months postoperatively.
The ICRS scale assesses histological quality of regenerated car-
tilaginous tissue in a systematic and objective way, with six parallel
criteria. The “cell distribution” criterion considers that chon-
drocytes in the middle and lower zone of healthy mature cartilage
distribute in a columnar pattern, and the cluster pattern is less
favorable30. However, the columnar pattern of chondrocyte distri-
bution is derived from endochondral ossiﬁcation of epiphysis dur-
ing bone maturation48, and may not necessarily rebuild in
regenerated cartilage. The cell distribution in our biopsy specimens
was all a mixed columnar-cluster pattern. Although cluster pattern
has been considered a negative feature associated with degener-
ation in osteoarthritis tissue, its presence in immature and devel-
oping cartilage may indicate remodeling of cartilage tissue during
the healing process49. The ICRS scale uses HE staining to evaluate
the nature of matrix, and does not recommend the use of special
staining. We also found HE staining useful in deﬁning the texture of
the cells in regenerated cartilaginous tissue. However, we also re-
gard special staining, such as the Alcian blue and immunohisto-
logical staining, helpful to characterize chemical contents of the
cartilaginousmatrix. Beside histological characteristics, mechanical
properties of regenerated cartilage are also important for such
tissue to bear weight. Althoughwe previously used indentation test
to deﬁne the viscoelastic nature of regenerated cartilage in an an-
imal model25, such test was hardly applicable in the clinical setting.
KOOS is validated for several knee disabilities, including focal
cartilage lesions50.AmongtheﬁvesubscalesofKOOS, theQoLsubscale
is the most disease-speciﬁc and best discriminates focal cartilage
defects from other knee diseases such as deﬁciency of anterior cru-
ciate ligament1. After the surgery, we observed the largest increase in
score in QoL subscale among all subscales. Contrarily, the Symptom
subscale concerns primarily with knee motion, which is not usually
affected by focal cartilage lesions. Our patients had amean Symptoms
score of 83 pre-operatively, and the score had not increased sig-
niﬁcantly postoperatively until the follow-up at 24 months.
In conclusion, our preliminary ﬁndings indicate that the
biphasic cylindrical construct does not bear any serious AE after
implantation, therefore is safe for clinical use. The constructs are
securely press-ﬁt without additional ﬁxation, and support regen-
eration of articular cartilage to repair the original chondral defect.
Cancellous bone formed in the osseous phase without pre-seeding
of cells. This single-stage implantation of double-minced autolo-
gous cartilage with the biphasic osteochondral composite presents
an alternative to mosaicplasty, without the limitations of insufﬁ-
cient graft resource and donor site morbidity.
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